Ramsey Christian N, Newman Charles B, Jones Michael R, Archer Anona, Given Curtis A
Baptist Health Lexington, Lexington, KY, USA.
Interv Neuroradiol. 2020 Feb;26(1):10-18. doi: 10.1177/1591019919863435. Epub 2019 Jul 16.
Emergent large vessel occlusive (ELVO) stroke secondary to underlying carotid occlusive disease is frequently encountered in endovascular ischemic stroke therapy and trials. Up to 29% of all cerebral vascular accidents are attributed to severe carotid occlusive disease, and recent interventional trials have demonstrated this occurrence in 18.6-32.2% of ELVO stroke. We present a novel technique using the stent retriever guide wire to expedite angioplasty and/or stent placement for associated carotid occlusive disease during mechanical thrombectomy of ELVO stroke. This technique utilizes the "waiting time" during stent retriever integration within the thrombus as an opportunity to initiate revascularization of the cervical carotid, using the deployed stent retriever guidewire as an ad hoc rapid exchange wire while the stentriever serves as a potential surrogate distal embolic protection device. We present 23 cases using this novel endovascular approach, which we have called the , as the cervical lesion is only traversed once during therapy.
A case series of 23 consecutive patients who underwent a novel endovascular technique for treating tandem ICA origin and intracranial occlusive lesions is presented. Endpoints measured were time to re-perfusion, rates of intracranial hemorrhage and clinical outcomes (mRS at 30 and 90 days).
Average procedure time for revascularizing both the carotid and intracranial lesions was 52 min. A symptomatic ICH rate of 9% was observed. Seventy-four percent of patients had an mRS of 0-2 at follow-up.
The single-cross technique appears to be a safe and effective option for treating tandem occlusive lesions in the setting of ELVO.
在血管内缺血性卒中治疗及试验中,潜在颈动脉闭塞性疾病继发的急性大血管闭塞(ELVO)性卒中很常见。所有脑血管意外中高达29%归因于严重的颈动脉闭塞性疾病,近期的介入试验表明,在18.6%-32.2%的ELVO性卒中中存在这种情况。我们介绍一种新技术,即在ELVO性卒中机械取栓期间,使用支架取栓导丝加快相关颈动脉闭塞性疾病的血管成形术和/或支架置入。该技术利用支架取栓器在血栓内整合的“等待时间”,以已置入的支架取栓导丝作为临时快速交换导丝,同时支架取栓器作为潜在的替代远端栓子保护装置,启动颈段颈动脉的血管再通。我们展示了23例采用这种新型血管内方法的病例,该方法我们称为,因为在治疗过程中颈部病变仅被穿过一次。
呈现一组连续23例患者的病例系列,这些患者接受了一种新型血管内技术治疗串联的颈内动脉起始部和颅内闭塞性病变。测量的终点指标为再灌注时间、颅内出血发生率和临床结局(30天和90天时的改良Rankin量表评分)。
颈动脉和颅内病变血管再通的平均手术时间为52分钟。观察到有症状颅内出血发生率为9%。74%的患者在随访时改良Rankin量表评分为0-2分。
单交叉技术似乎是治疗ELVO情况下串联闭塞性病变的一种安全有效的选择。